key: cord-0812469-oke224mq
authors: Jing, Hongwu; Ackerman, William E.; Zhao, Guomao; El Helou, Yara; Buhimschi, Catalin S.; Buhimschi, Irina A.
title: Connecting the Dots on Vertical Transmission SARS-CoV-2 Using Protein-Protein Interaction Network Analysis – Potential roles of placental ACE2 and ENDOU
date: 2020-11-09
journal: Placenta
DOI: 10.1016/j.placenta.2020.11.001
sha: ca819c2e9f0e9f2e47bfbd5fcc82303724370df8
doc_id: 812469
cord_uid: oke224mq

We conducted a protein-protein interaction (PPI) network study searching for proteins relevant to pregnancy-associated COVID-19 in pregnancy complicated with severe preeclampsia (sPE) and intra-amniotic infection and/or inflammation (Triple-I). PPI networks from sPE and Triple-I were intersected with the PPI network from coronavirus infection. Common proteins included the SARS-CoV-2 entry receptor ACE2, and ENDOU, a placental endoribonuclease homologous to Nsp15, a protein produced by the virus to escape host immunity. Remarkably, placental ENDOU mRNA expression far exceeded that of ACE2. Immunohistochemistry confirmed ENDOU localization at the hemochorial maternal-fetal interface. Investigation of ENDOU’s relevance to vertical transmission of SARS-CoV-2 is further warranted.

SARS-CoV-2 is the etiologic agent of COVID-19 which phenotypically manifests with fever, 22 malaise, severe pneumonia and lethal systemic inflammatory syndrome. Experiences from the 23 1918-1919 influenza epidemic and most recently from the 2015 Zika virus outbreak support the 24 hypothesis that pregnant women may be more vulnerable during viral pandemics [1, 2, 3] . 25 Placenta is generally considered a barrier to vertical transmission. Only a few viruses are proven 26 to cause fetal infection [4] . SARS-CoV-2 is an emergent viral pathogen whose ability to infect 27 the human fetus remains unknown. A case report of COVID-19 associated with preeclampsia 28 symptoms showed that SARS-CoV-2 is able to infect the placental syncytiotrophoblast [5] .

COVID-19 infection carries overlapping phenotypic features with preeclampsia as surveilled by 30 clinical cohorts worldwide [6, 7] . These preliminary observations led us to explore possible high homology with the coronavirus endoribonuclease Nsp15 [ 13 ] (Fig. 1C) , and Human 64 RT-PCR confirmed mRNA expression of ACE2 and ENDOU in placenta with a significantly 69 higher ENDOU abundance both in iPTB and term placenta ( Fig. 2A) . ACE2 mRNA expression 70 was downregulated in Triple-I and term placenta (Fig. 2B) and IHC confirmed the decrease in 71 signal intensity in syncytiotrophoblast and inflammatory cells in Triple-I (Fig. 2 D and E) .

Conversely, ENDOU mRNA expression was upregulated in preeclampsia (Fig. 2C ) and ENDOU 73 staining was highly increased in syncytiotrophoblast of preeclamptic placenta (Fig. 2 F and G) . increased infectivity [16, 17] . ENDOU, or PP11, is a scarcely studied protein. PP11 was first 82 purified in the 1980s and thought to function as a serine protease [ 18] . Subsequent work 83 demonstrated that ENDOU is an RNA endonuclease capable of generating small RNA fragments 84 in a Mn 2+ -dependent fashion [17] . Aside from placenta, ENDOU is expressed ectopically in 85 several malignant tumors [19] . The observed increased ENDOU expression in the preeclamptic preeclampsia [20] . Furthermore, ENDOU's endoribonuclease roles may be linked to cell-free 88 RNA signatures released by placenta in maternal plasma [21] . As for COVID-19, it is important 89 to determine if placental ENDOU cooperates in any way with coronavirus Nsp15 to enhance or 90 diminish the effectiveness of the placental barrier. We observed that, in the human placenta, 91 ENDOU is significantly more abundant than ACE2. This is interesting because it suggests that 92 while the cellular gate receptor for SARS-CoV-2 (ACE2) is less represented, the 93 endoribonuclease activity favoring viral infectivity is present [22] . Collectively, our data suggest 94 a potentially active mechanism that may favor SARS-Cov-2 trans-placental transmission that 

Effects of influenza on pregnant women and infants

Emerging role of Zika virus in adverse fetal and neonatal outcomes

Zika virus takes a transplacental route to infect fetuses: insights from an animal model

The placenta as a barrier to viral infections

SARS-CoV-2 infection of the placenta

Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study

Prevalence and neighborhood geomapping of COVID-19 in an underserved Chicago pregnant population

Cytoscape: A software environment for integrated models of biomolecular interaction networks

Human placenta expresses α2-adrenergic receptors and may be implicated in pathogenesis of preeclampsia and fetal growth restriction

Comprehensive RNA profiling of villous trophoblast and decidua basalis in pregnancies complicated by preterm birth following intraamniotic infection

DyNet: visualization and analysis of dynamic molecular interaction networks

Cytoscape StringApp: network analysis and visualization of proteomics data

An "Old" protein with a new story: Coronavirus endoribonuclease is important for evading host antiviral defenses

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s

Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2

The tumor marker human placental protein 11 is an endoribonuclease

12) in human term placentae

Ectopic production of placenta-"specific" tissue proteins (PP5 and PP11) by malignant breast tumors

COVID-19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients

Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development

Biochemical and Genetic Analyses of Murine Hepatitis Virus Nsp15

The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Hongwu Jing, William E. Ackerman IV, Guomao Zhao, Yara El Helou, Catalin S. Buhimschi,The authors whose names are listed immediately below report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript. Please specify the nature of the conflict on a separate sheet of paper if the space below is inadequate.

None.

This statement is signed by all the authors to indicate agreement that the above information is true and correct (a photocopy of this form may be used if there are more than 10 authors):Author's name (typed)Author's signature Date